Across healthcare and life sciences, CRM migrations are accelerating. To keep up with stricter regulatory expectations, rising patient demands, technological advancement, new use cases, and the growing volume of clinical
A large, three-year clinical trial designed to demonstrate how Grail’s blood test for early cancer detection could work in a broad population has preliminary results showing reduction in late-stage cancer
With hospitals facing ongoing financial pressures, including rising costs and declining reimbursement rates, they’re looking for tools that not only improve efficiency — but also increase revenue. Mercyhealth seems to
Rainfall Health, an AI-powered compliance and reimbursement platform for hospitals and medical groups, has raised $15 million in Series A funding, it announced on Wednesday. The San Francisco-based company helps
Global life sciences giant Danaher coughed up a pretty penny to buy Masimo this week, spending roughly $10 billion to beef up its diagnostics portfolio. The deal values medical device
Frist Cressey Ventures closed a $425 million fund, which it will use to invest in early-stage healthcare companies focused on bringing down costs and leveraging AI, the firm announced on
America’s mental health crisis is often framed as a clinician shortage problem. Demand for appointments is rising faster than availability, waitlists are growing, and burnout is pushing clinicians out of
When OpenAI introduced ChatGPT Health to help consumers direct their health and wellness questions to its now ubiquitous bot, the chief medical officer of the dominant electronic health record company
Solera Health, a digital health delivery company, unveiled its new behavioral health network on Tuesday with Calm Health and Lyra Health as partners. Phoenix, Arizona-based Solera Health works with payers
Eli Lilly has been scouting for drugs to follow the trail blazed by its blockbuster cardiometabolic medicines. Its latest pipeline-building deal has the pharmaceutical company paying $100 million for rights
